Guardion Health Sciences appoints Jan Hall as CEO; Bret Scholtes resigns effective June 9, 2023

Guardion Health Sciences, Inc.

Bret Scholtes resigns as President, CEO, and director effective June 9, 2023; no disagreement with company.
Jan Hall appointed President and CEO effective June 19, 2023; former Neutrogena North America President and Coca-Cola SVP.
Hall's employment: $370,000 base salary, target bonus up to 100% of base, severance up to 12 months.
Board reduced from five to four directors effective June 10, 2023.

item 5.02 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Bret Scholtes

President and Chief Executive Officer

Guardion Health Sciences, Inc.

Effective: 2023-06-09
Successor: Janet Hall
Filed: May 30, 2023, 7:59 PM ET

accepted the resignation of Bret Scholtes, the Company’s President and Chief Executive Officer, effective as of June 9, 2023

Appointed

Janet Hall

President and Chief Executive Officer

Guardion Health Sciences, Inc.

Effective: 2023-06-19
Filed: May 30, 2023, 7:59 PM ET

Effective as of June 19, 2023, the Company appointed Janet (“Jan”) Hall as the Company’s President and Chief Executive Officer.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Bret Scholtes resigned as President and Chief Executive Officer at Guardion Health Sciences, Inc..

Action: resigned
Role: President and Chief Executive Officer

Exact text from the filing

accepted the resignation of Bret Scholtes, the Company’s President and Chief Executive Officer, effective as of June 9, 2023

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 1.0

Janet Hall was appointed as President and Chief Executive Officer at Guardion Health Sciences, Inc..

Action: appointed
Role: President and Chief Executive Officer

Exact text from the filing

Effective as of June 19, 2023, the Company appointed Janet (“Jan”) Hall as the Company’s President and Chief Executive Officer.

View on SEC.gov

Source: SEC EDGAR

accession 0001493152-23-019500

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.